Guggenheim Capital’s Zymeworks ZYME Stock Holding History

Guggenheim Capital’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-18,831	Closed	-$116K	–	2008
2022 Q3	$116K	Sell	18,831 -1,083	-5%	-$6.53K	﹤0.01%	1837
2022 Q2	$106K	Sell	19,914 -799	-4%	-$4.83K	﹤0.01%	2005
2022 Q1	$136K	Buy	+20,713	New	+$185K	﹤0.01%	2086
2021 Q4	–	Sell	-21,133	Closed	-$614K	–	2243
2021 Q3	$614K	Sell	21,133 -490	-2%	-$16.3K	﹤0.01%	1669
2021 Q2	$750K	Buy	21,623 +990	+5%	+$31.4K	﹤0.01%	1640
2021 Q1	$652K	Buy	20,633 +9,840	+91%	+$400K	﹤0.01%	1593
2020 Q4	$510K	Buy	+10,793	New	+$501K	﹤0.01%	1635

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Guggenheim Capital's ZYME Position: Q4 2022 in Review

Guggenheim Capital sold out of Zymeworks (ZYME) in Q4 2022, closing a stake of 18,831 shares — an estimated $116K sold.

Guggenheim Capital first reported a position in ZYME in Q4 2020 and held it in 7 quarters. The position peaked at $750K in Q2 2021. 96 funds tracked by Wall St. Rank hold ZYME as of Q4 2022.

Guggenheim Capital reported no remaining Zymeworks position as of Q4 2022 after selling out during the quarter.
Guggenheim Capital sold 18,831 Zymeworks shares in Q4 2022, an estimated $116K.
Guggenheim Capital first reported a position in Zymeworks in Q4 2020 and held it in 7 quarters.
Guggenheim Capital's Zymeworks position peaked at $750K in Q2 2021.
96 funds tracked by Wall St. Rank held Zymeworks as of Q4 2022.

Based on Guggenheim Capital's 13F filing for Q4 2022, filed 14 Feb 2023.